Amgen (NASDAQ:AMGN) Price Target & New Coverage by Deutsche Bank

The financial firm Deutsche Bank has has initiated coverage on Amgen (NASDAQ:AMGN)’s stock, rating it Hold while giving it the TP at $172.0.

Despite the new coverage NASDAQ:AMGN is right now trading 0.00% lower at $173.82 as of 8:06 AM New York time. Amgen shares have [From2] 0% in the past 200 days, while the S&P500 has surged 6.00% during the same time period.

Out of 17 brokers covering Amgen, 11 rate it a Buy, 10 indicate a Hold while 0 suggest a Sell. The highest target is $206 and the lowest is $157 according to Thomson/First Call. The 12-month mean target is $183.88, which means upside potential of 5.79% over the current price.

Institutional Ownership

Krensavage Asset Management Llc had the most significant stake with ownership of 126,038 shares as of Q2 2015 for 7.6% of the portfolio. Smead Capital Management Inc. is another bull as the institutional investor who is having 851,682 shares of Amgen or 6.77% of their portfolio. Also, Merriman Wealth Management Llc have 5.51% of their portfolio invested in the company for 160,464 shares. The New York-based fund F&V Capital Management Llc revealed it had acquired so far a stake worth about 5.01% of the institutional investor’s stock portfolio in Amgen. The New York-based fund Iat Reinsurance Co Ltd. is also positive about the stock, possessing 43,455 shares or 4.7% of their portfolio.

Amgen (NASDAQ:AMGN) Profile

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment.

Amgen (NASDAQ:AMGN) closed at $173.82 yesterday. A total of 4,057 shares of the company’s stock traded hands. This is down from average of 3.58 million shares. Amgen has a 52 week low of $133.64 and a 52 week high of $184.21. The company has a market cap of $129.67 billion and a P/E ratio of 16.47.

Get the latest Amgen (NASDAQ:AMGN) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post Deutsche Bank Has Started Amgen (NASDAQ:AMGN) Stock Coverage With a Hold Rating and Price Objective of $172.0 appeared first on Octafinance.